Home › Funds › CAMPBELL NEWMAN ASSET MANAGEMENT INC › CPRX

CAMPBELL NEWMAN ASSET MANAGEMENT INC position in CPRX

CATALYST PHARMACEUTICALS INC

CAMPBELL NEWMAN ASSET MANAGEMENT INC reported holding 96,690 shares of CPRX (CATALYST PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$3.0M, representing 0.23% of its reported portfolio and ranking #49 among its reported holdings. CAMPBELL NEWMAN ASSET MANAGEMENT INC has disclosed CPRX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)96.69K sh
Reported value held$3.04M
Portfolio Weight0.23%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CAMPBELL NEWMAN ASSET MANAGEMENT INC's CPRX position evolved

CAMPBELL NEWMAN ASSET MANAGEMENT INC first disclosed a stake in CPRX in Q1 2024 at 89,472 shares (US$1.4M). The position peaked in Q2 2026 at 96,690 shares, worth US$3.0M. Across 10 filings, CAMPBELL NEWMAN ASSET MANAGEMENT INC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 96,690 shares valued at US$3.0M — an increase of 4,214 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2024 89.47K $1.43M New
Q2 2024 89.78K $1.39M Hold
Q3 2024 88.34K $1.76M Reduce
Q4 2024 88.12K $1.84M Hold
Q1 2025 87.73K $2.13M Hold
Q2 2025 93.97K $2.04M Add
Q3 2025 94.37K $1.86M Hold
Q4 2025 90.92K $2.12M Reduce
Q1 2026 92.48K $2.29M Add
Q2 2026 96.69K $3.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CPRX and 13F data

CPRX (CATALYST PHARMACEUTICALS INC) is a company whose sector is not yet classified in our data. 43 other funds we track also report a position in CPRX — the largest reported positions include GLAZER CAPITAL, LLC (US$113.2M), HBK INVESTMENTS L P (US$88.6M), NEXPOINT ASSET MANAGEMENT, L.P. (US$50.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CPRX

All CPRX fund holders →

FAQ

How long has CAMPBELL NEWMAN ASSET MANAGEMENT INC held CPRX?

CAMPBELL NEWMAN ASSET MANAGEMENT INC has disclosed CPRX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is CAMPBELL NEWMAN ASSET MANAGEMENT INC's current position in CPRX?

As of Q2 2026, CAMPBELL NEWMAN ASSET MANAGEMENT INC holds 96.69K shares of CPRX (CATALYST PHARMACEUTICALS INC), valued at $3.04M, representing 0.23% of its reported portfolio and ranking #49.

Has CAMPBELL NEWMAN ASSET MANAGEMENT INC been buying or selling CPRX?

In the latest 13F filing (Q2 2026), CAMPBELL NEWMAN ASSET MANAGEMENT INC increased its position in CPRX. The position peaked in Q2 2026 at 96.69K shares.

Which other funds hold CPRX?

Other major institutional holders of CPRX include GLAZER CAPITAL, LLC, HBK INVESTMENTS L P, NEXPOINT ASSET MANAGEMENT, L.P., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.